These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39061022)

  • 1. Validity of the Chinese multimorbidity-weighted index in measuring disease burden using health check-ups data in primary care.
    Lai YS; Gao XY; Hu WH; Liu YX; Zhang YJ; Liu JC; Yang C; Liao J
    BMC Public Health; 2024 Jul; 24(1):1999. PubMed ID: 39061022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and validating a Chinese multimorbidity-weighted index for middle-aged and older community-dwelling individuals.
    Hu WH; Liu YY; Yang CH; Zhou T; Yang C; Lai YS; Liao J; Hao YT
    Age Ageing; 2022 Feb; 51(2):. PubMed ID: 35211718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-rated health, interviewer-rated health, and objective health, their changes and trajectories over time, and the risk of mortality in Chinese adults.
    Shan S; Cao J; Tang K; Cheng S; Ren Z; Li S; Sun W; Hou L; Yi Q; Chen D; Song P
    Front Public Health; 2023; 11():1137527. PubMed ID: 37408749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between polypharmacy and 2-year outcomes among Chinese older inpatients: a multi-center cohort study.
    Liu X; Zhao R; Zhou X; Yu M; Zhang X; Wen X; Jin J; Wang H; Lv D; Zhao S; Jiao J; Wu X; Xu T
    BMC Geriatr; 2024 Sep; 24(1):748. PubMed ID: 39251936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity.
    Schneider C; Aubert CE; Del Giovane C; Donzé JD; Gastens V; Bauer DC; Blum MR; Dalleur O; Henrard S; Knol W; O'Mahony D; Curtin D; Lee SJ; Aujesky D; Rodondi N; Feller M
    JAMA Netw Open; 2022 Jul; 5(7):e2223911. PubMed ID: 35895059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national cohort study.
    Ye X; Zhang G; Han C; Wang P; Lu J; Zhang M
    Front Endocrinol (Lausanne); 2024; 15():1381949. PubMed ID: 38601202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-Related Quality of Life and Health Service Use among Multimorbid Middle-Aged and Older-Aged Adults in China: A Cross-Sectional Study in Shandong Province.
    Zhao Q; Wang J; Nicholas S; Maitland E; Sun J; Jiao C; Xu L; Leng A
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity and care dependence in older adults: a longitudinal analysis of findings from the 10/66 study.
    Bao J; Chua KC; Prina M; Prince M
    BMC Public Health; 2019 May; 19(1):585. PubMed ID: 31096943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Childhood Experiences and Subsequent Chronic Diseases Among Middle-aged or Older Adults in China and Associations With Demographic and Socioeconomic Characteristics.
    Lin L; Wang HH; Lu C; Chen W; Guo VY
    JAMA Netw Open; 2021 Oct; 4(10):e2130143. PubMed ID: 34694390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation, cultural adaptation and validation of the Chinese Multimorbidity Treatment Burden Questionnaire(C-MTBQ): a study of older hospital patients.
    Dou L; Huang J; Duncan P; Guo L
    Health Qual Life Outcomes; 2020 Jun; 18(1):194. PubMed ID: 32571343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multimorbidity coexistence on the risk of mortality in the older adult population in China.
    Su Z; Huang L; Zhu J; Cui S
    Front Public Health; 2023; 11():1110876. PubMed ID: 37089511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, patterns of multimorbidity and associations with health care utilization among middle-aged and older people in China.
    Zhong Y; Qin G; Xi H; Cai D; Wang Y; Wang T; Gao Y
    BMC Public Health; 2023 Mar; 23(1):537. PubMed ID: 36944960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Functioning Decline and Mortality in Older Adults With Multimorbidity: Joint Modeling of Longitudinal and Survival Data.
    Wei MY; Kabeto MU; Galecki AT; Langa KM
    J Gerontol A Biol Sci Med Sci; 2019 Jan; 74(2):226-232. PubMed ID: 29529179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of changes in waist circumference, waist-to-height ratio and weight-adjusted-waist index with multimorbidity among older Chinese adults: results from the Chinese longitudinal healthy longevity survey (CLHLS).
    Chen ZT; Wang XM; Zhong YS; Zhong WF; Song WQ; Wu XB
    BMC Public Health; 2024 Jan; 24(1):318. PubMed ID: 38287292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a multimorbidity risk prediction nomogram among Chinese middle-aged and older adults: a retrospective cohort study.
    Zheng X; Xue B; Xiao S; Li X; Chen Y; Shi L; Liang X; Tian F; Zhang C
    BMJ Open; 2023 Nov; 13(11):e077573. PubMed ID: 37940154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating multiple morbidity disease burden among older persons: a convergent construct validity study to discriminate among six chronic illness measures, CCHS 2008/09.
    Wister AV; Levasseur M; Griffith LE; Fyffe I
    BMC Geriatr; 2015 Feb; 15():12. PubMed ID: 25887137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study.
    Dugravot A; Fayosse A; Dumurgier J; Bouillon K; Rayana TB; Schnitzler A; Kivimaki M; Sabia S; Singh-Manoux A
    Lancet Public Health; 2020 Jan; 5(1):e42-e50. PubMed ID: 31837974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
    Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
    Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of adiposity indices with cardiometabolic multimorbidity among 101,973 chinese adults: a cross-sectional study.
    Qin X; Chen C; Wang J; Cai A; Feng X; Jiang X; Feng Y
    BMC Cardiovasc Disord; 2023 Oct; 23(1):514. PubMed ID: 37865773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.